| Name | Title | Contact Details |
|---|
Neuroplasticity targeting electrical fields delivered by a wearable interface, to help the brain regain control of immune function
Terumo Medical Corporation (TMC), a leading medical device manufacturer employs approximately 700 people in offices throughout the United States, with its corporate headquarters located in Somerset, NJ.
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Boas Surgical Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Allentown, PA. To find more information about Boas Surgical Inc, please visit www.boassurgical.com
More than 65 academic medical centers use ARUP as their primary reference laboratory and ARUP also provides all laboratory services, including phlebotomy and support services, for the 490-bed University of Utah Hospitals and Clinics. ARUP's 1,700